Literature DB >> 9372876

Nephrogenic adenoma of the bladder in renal transplant and non-renal transplant patients: a review of 22 cases.

V Tse1, M Khadra, D Eisinger, A Mitterdorfer, J Boulas, J Rogers.   

Abstract

OBJECTIVES: To review diagnoses of nephrogenic adenoma and in particular to evaluate its association with transitional cell carcinoma (TCC) of the bladder and its relationship to renal transplantation.
METHODS: A retrospective review of 22 cases of nephrogenic adenoma (NA) diagnosed between 1989 and 1996 was conducted, 7 of which were in renal transplant patients. Data collected in each case included demographic details, predisposing factors, associated urologic pathology, mode of presentation, cystoscopic finding, management, and follow-up.
RESULTS: There was a 3:1 predominance of men. Mean follow-up was 21.4 months (range 3 to 50). Six patients (27%) had one or more recurrences. All 22 patients had some form of previous bladder insult or surgery, including recurrent urine infections, urinary tract instrumentation, placement of ureteric stents, cystodiathermy, and open bladder surgery. Six cases were associated with TCC of the bladder, of which 4 had NA lesions directly over or close to the site of previous fulguration. In 4 patients, there was a temporal relationship between the administration of intravesical doxorubicin hydrochloride or bacille Calmette-Guérin (BCG) and the onset of NA lesions. One case was associated with an inverted papilloma that had not been described before. In 7 renal transplant cases, 3 lesions were found contralateral to the side of the ureterovesical anastomosis. All 22 cases were benign histologically, but one NA was found within a low-grade baldder TCC. Nineteen cases were followed up regularly with no malignant transformation. Three patients were lost to follow-up.
CONCLUSIONS: This study has demonstrated an association between NA and bladder cancer. Patients with NA, especially those treated with intravesical chemotherapy or BCG, should have regular cystoscopies. Fulguration or transurethral resection appear to be sufficient treatment. No renal transplant patients had vesical TCC and NA simultaneously. Neither immunosuppression nor ureterovesical anastomosis appeared to be a significant predisposing factor in the transplant patients.

Entities:  

Mesh:

Year:  1997        PMID: 9372876     DOI: 10.1016/S0090-4295(97)00334-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Adenocarcinoma of the bladder following nephrogenic adenoma: a case report.

Authors:  Edwin Hungerhuber; Ekkehard Bach; Arndt Hartmann; Dominic Frimberger; Christian Stief; Dirk Zaak
Journal:  J Med Case Rep       Date:  2008-05-18

2.  The progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinoma: a case report.

Authors:  Catharine A Dhaliwal; Paul W Fineron
Journal:  Curr Urol       Date:  2012-09-27

3.  Recurrent nephrogenic adenoma in a 10-year-old boy with prune belly syndrome : a case presentation.

Authors:  Vijaya M Vemulakonda; Ryan P Kopp; Mathew D Sorensen; Richard W Grady
Journal:  Pediatr Surg Int       Date:  2007-11-28       Impact factor: 1.827

4.  Nephrogenic adenoma of the bladder: a single institution experience assessing clinical factors.

Authors:  Yooni Yi; Angela Wu; Anne P Cameron
Journal:  Int Braz J Urol       Date:  2018 May-Jun       Impact factor: 1.541

Review 5.  Nephrogenic Adenoma of the Urinary Bladder: A Review of the Literature.

Authors:  Anthony Kodzo-Grey Venyo
Journal:  Int Sch Res Notices       Date:  2015-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.